Biosensors for Real-time Monitoring of Neurotransmitters: Applications in Neurological Disorders

Haitham Bakheit^*
*Correspondence: Haitham Bakheit, Department of Pharmaceutical Chemistry, King Saud University, Riyadh, Saudi Arabia, Email:

Introduction

Neurological disorders, ranging from Parkinson's disease to depression, have a profound impact on millions of lives worldwide. A key challenge in managing these disorders is the real-time monitoring of neurotransmitter dynamics within the brain. Neurotransmitters are chemical messengers that play a fundamental role in brain function and can be indicative of disease progression or treatment response. The development of biosensors for real-time monitoring of neurotransmitters has emerged as a transformative approach to address this challenge. This article explores the applications of biosensors in real-time monitoring of neurotransmitters, particularly in the context of neurological disorders. These biosensors offer a window into the dynamic chemical processes occurring in the brain, allowing for early disease detection, personalized treatment strategies, and insights into the underlying mechanisms. We delve into the principles of biosensors, their design, and their applications in neurological research and clinical practice [1].

Description

In this section, we provide a detailed account of biosensors for real-time monitoring of neurotransmitters and their applications in neurological disorders:

Principles of biosensors: The article explains the fundamental principles underlying biosensors, focusing on their ability to detect specific neurotransmitters in real-time. Biosensors typically consist of a recognition element (e.g., enzymes, antibodies, or nanomaterials) and a transducer (e.g., electrodes or optical sensors) that converts the chemical signal into a measurable output [2].

Neurotransmitter detection: We delve into the specific neurotransmitters targeted by biosensors, including dopamine, serotonin, glutamate, and others. These neurotransmitters are implicated in various neurological disorders, making their real-time monitoring highly relevant [3].

Biosensor design and engineering: This section explores the design considerations and engineering aspects of biosensors for neurotransmitter monitoring. We discuss nanomaterial-based biosensors, microelectrode arrays, and other emerging technologies used to enhance sensitivity, selectivity, and temporal resolution [4].

Applications in neurological disorders: The article highlights the wide-ranging applications of biosensors in neurological research and clinical practice. These applications include monitoring neurotransmitter fluctuations in neurodegenerative diseases (e.g., Parkinson's and Alzheimer's), neuropsychiatric disorders (e.g., depression and schizophrenia), and epilepsy. Biosensors also facilitate the evaluation of treatment responses and the development of targeted interventions.

Challenges and future directions: We address the challenges associated with biosensor technology, such as biocompatibility, sensor stability, and minimally invasive implantation. Moreover, we discuss potential future directions, including the integration of biosensors with neural implants and closed-loop therapeutic interventions [5].

Conclusion

In conclusion, biosensors for real-time monitoring of neurotransmitters represent a cutting-edge approach to understanding and managing neurological disorders. These devices provide a means to decipher the complex chemical signaling within the brain, offering valuable insights into disease mechanisms and treatment strategies. By enabling the real-time tracking of neurotransmitter dynamics, biosensors empower clinicians and researchers to make informed decisions, optimize treatment plans, and potentially intervene at critical moments in neurological disease progression.

As biosensor technology continues to advance, it holds great promise for transforming the landscape of neurological research and clinical care. The ability to monitor neurotransmitters in real-time opens new avenues for early disease detection, personalized medicine, and innovative therapies, ultimately improving the quality of life for individuals affected by neurological disorders.

References

1. Komoto, Yuki, Takahito Ohshiro, Takeshi Yoshida and Masateru Taniguchi, et al. "Time-resolved neurotransmitter detection in mouse brain tissue using an artificial intelligence-nanogap." Sci Rep 10 (2020): 11244.

Google Scholar, Crossref, Indexed at

2. Adotevi, Nadia, Aini Su, Danushi Peiris and Beulah Leitch, et al. "Altered neurotransmitter expression in the corticothalamocortical network of an absence epilepsy model with impaired feedforward inhibition." Neurosci 467 (2021): 73-80.

Google Scholar, Crossref, Indexed at

3. Cao, Qinjingwen, Yijia Wang, Bingming Chen and Lingjun Li, et al. "Visualization and identification of neurotransmitters in crustacean brain via multifaceted mass spectrometric approaches." ACS Chem Neurosci 10 (2019): 1222-1229.

Google Scholar, Crossref, Indexed at

4. Banerjee, Saikat, Stephanie McCracken, Md Faruk Hossain and Gymama Slaughter. "Electrochemical detection of neurotransmitters." Biosensors 10 (2020): 101.

Google Scholar, Crossref, Indexed at

5. Jackson, Brad P., Susanne M. Dietz and R. Mark Wightman. "Fast-scan cyclic voltammetry of 5-hydroxytryptamine." Anal Chem 67 (1995): 1115-1120.

Google Scholar, Crossref, Indexed at